Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Tuesday, November 11, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
FDA Approves Promega OncoMate MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA and LENVIMA in Advanced Endometrial Carcinoma
Life Sciences Times
-
November 11, 2025
Pharma
City Therapeutics Announces Submission of Application for Clinical Trial of CITY-FXI, an Investigational RNAi Anticoagulant
Life Sciences Times
-
November 10, 2025
Pharma
AstraZeneca Reports Positive Phase III NATRON Results Showing FASENRA Delayed Disease Worsening in Hypereosinophilic Syndrome
Life Sciences Times
-
November 7, 2025
Pharma
Astria Therapeutics Reports Final Positive Results from All Enrolled HAE Patients in ALPHA-STAR Phase 1b/2 Trial of Navenibart
Life Sciences Times
-
November 6, 2025
Pharma
Calluna Pharma Receives U.S. FDA Orphan Drug Designation for CAL101 in Idiopathic Pulmonary Fibrosis
Life Sciences Times
-
October 31, 2025
Pharma
Delix Therapeutics Reports Positive Phase Ib Results for Zalsupindole and FDA Clearance for Phase II Trial with At-Home Administration
Life Sciences Times
-
October 28, 2025
0
Pharma
Corsera Health Files First Phase 1 Clinical Trial Application for Preventive RNAi Medicine Targeting Cardiovascular Disease
Life Sciences Times
-
October 27, 2025
0
Pharma
Zymeworks Reports Promising Early Data from Phase 1 Study of ZW191 Targeting Folate Receptor-Alpha in Advanced Solid Tumors
Life Sciences Times
-
October 24, 2025
0
Pharma
Verastem Oncology Reports Promising Early Results from Ongoing Trial of VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor
Life Sciences Times
-
October 24, 2025
0
Pharma
CDR-Life Reports Early Clinical Data Showing Pharmacodynamic Activity of CDR404 in MAGE-A4 Positive Solid Tumors
Life Sciences Times
-
October 24, 2025
0
Pharma
FDA Grants Priority Review for KEYTRUDA and KEYTRUDA QLEX, Each in Combination with Padcev, for Certain Patients with Muscle-Invasive Bladder Cancer
Life Sciences Times
-
October 23, 2025
0
Pharma
Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma
Life Sciences Times
-
October 23, 2025
0
Pharma
USAntibiotics Receives FDA National Priority Voucher for Domestic Antibiotic Manufacturing
Life Sciences Times
-
October 22, 2025
0
Pharma
IMFINZI Regimen Reduces Risk of Disease Recurrence or Death by 32% in High-Risk Non-Muscle-Invasive Bladder Cancer in Phase III POTOMAC Trial
Life Sciences Times
-
October 17, 2025
0
Pharma
Parabilis Medicines Unveils Groundbreaking Clinical Data Showing First-Ever Drugging of Key Cancer Driver with FOG-001
Life Sciences Times
-
October 17, 2025
0
Pharma
Delix Therapeutics Study Shows Non-Hallucinogenic Compound Zalsupindole Promotes Neuroplasticity Comparable to Ketamine and Psychedelics
Life Sciences Times
-
October 16, 2025
0
Pharma
Cycle Pharmaceuticals Launches PHYRAGO in U.S., Its First Oncology Treatment
Life Sciences Times
-
October 16, 2025
0
1
2
3
...
83
Page 1 of 83
Most Read
New Research: GLP-1 Therapies Could Reduce U.S. Mortality by 3.5% Over the Next Two Decades
November 11, 2025
ByHeart Expands Voluntary Nationwide Recall of Infant Formula as Investigation Continues
November 11, 2025
Rockwell Medical Names Rashad Brown Vice President of Manufacturing and Supply Chain
November 11, 2025
Electromedical Products International Expands Access to Alpha-Stim for Veterans with Anxiety, Insomnia, and Pain
November 11, 2025